Evidence map›Paper›PMID 34983010›Full record

Trial reportPsychiatry research2022

Effects of oxytocin administration on fear-potentiated acoustic startle in co-occurring PTSD and alcohol use disorder: A randomized clinical trial.

Christopher S Stauffer, Tyler E Morrison, Nathan K Meinzer, David Leung, Jessica Buffington, Evan G Sheh, Thomas C Neylan, Aoife O'Donovan, Joshua D Woolley

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychiatry research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Rat Models in Post-Traumatic Stress Disorder Research: Strengths, Limitations, and Implications for Translational Studies.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Christopher S StaufferDepartment of Psychiatry, Oregon Health & Science University, Portland, OR, USA; Portland Veterans Affairs Health Care Center, Portland, OR, USA. Electronic address: Christopher.Stauffer@va.gov.
Tyler E MorrisonDepartment of Psychiatry, University of California, San Diego, San Diego, CA, USA.
Nathan K MeinzerSlalom Consulting, LLC, Seattle, WA, USA.
David LeungSan Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Jessica BuffingtonSan Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Evan G ShehSan Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Thomas C NeylanSan Francisco Veterans Affairs Medical Center, San Francisco, CA, USA; Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.
Aoife O'DonovanSan Francisco Veterans Affairs Medical Center, San Francisco, CA, USA; Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.
Joshua D WoolleySan Francisco Veterans Affairs Medical Center, San Francisco, CA, USA; Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.
San Francisco VA Medical Center · USOregon Health & Science University · USUniversity of California, San Diego · US

Funding

6-week trial of oxytocin for co-occurring cocaine and opioid use disordersIK2CX001495 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI STAUFFER, CHRISTOPHER · 2017 to 2022
–
CSR&D Research Career Development Transition Award ApplicationIK4CX002090 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI WOOLLEY, JOSH · 2020 to 2024
–
CSRD VA IK2 CX001495CSRD VA IK4 CX002090
6 · The paper itself

Abstract

Co-occurring posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) is common and particularly associated with elevation of hyperarousal compared to PTSD alone. Treatment options are limited. Oxytocin regulates physiological stress response. Intranasal oxytocin administration has demonstrated potential in reducing symptoms of both PTSD and AUD. This study addresses a gap in the literature by investigating effects of intranasal oxytocin on startle reactivity, an important potential marker of both PTSD and AUD symptomatology. This is a randomized, double-blind, placebo-controlled, within- and between-participant, crossover, dose-ranging study examining the effects of a single administration of oxytocin 20 IU versus 40 IU versus placebo on psychophysiological responses to a common laboratory fear-potentiated acoustic startle paradigm in participants with PTSD-AUD (n = 47) and controls (n = 37) under three different levels of threat. Contrary to our hypothesis, for the PTSD-AUD group, oxytocin 20 IU had no effect on startle reactivity, while oxytocin 40 IU increased measures of startle reactivity. Additionally, for PTSD-AUD only, ambiguous versus low threat was associated with an elevated skin conductance response. For controls only, oxytocin 20 IU versus placebo was associated with reduced startle reactivity.

Indexed as

AlcoholismStress Disorders, Post-TraumaticAcousticsFearHumansOxytocinReflex, StartleOxytocinAlcoholismComorbidityOxytocinPost-traumaticPsychophysiologyReflexStartleStress disorders

Identifiers

PMID34983010
PMCPMC9074818
OpenAlexW4200106443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.